68 related articles for article (PubMed ID: 21057675)
1. Lipid and ganglioside alterations in tumor cells treated with antimitotic oleyl glycoside.
García-Álvarez I; Egido-Gabás M; Romero-Ramírez L; Doncel-Pérez E; Nieto-Sampedro M; Casas J; Fernández-Mayoralas A
Mol Biosyst; 2011 Jan; 7(1):129-38. PubMed ID: 21057675
[TBL] [Abstract][Full Text] [Related]
2. Detection of metabolite changes in C6 glioma cells cultured with antimitotic oleyl glycoside by 1H MAS NMR.
García-Alvarez I; Garrido L; Doncel-Pérez E; Nieto-Sampedro M; Fernández-Mayoralas A
J Med Chem; 2009 Mar; 52(5):1263-7. PubMed ID: 19199478
[TBL] [Abstract][Full Text] [Related]
3. New oleyl glycoside as anti-cancer agent that targets on neutral sphingomyelinase.
Romero-Ramírez L; García-Álvarez I; Casas J; Barreda-Manso MA; Yanguas-Casás N; Nieto-Sampedro M; Fernández-Mayoralas A
Biochem Pharmacol; 2015 Sep; 97(2):158-72. PubMed ID: 26206186
[TBL] [Abstract][Full Text] [Related]
4. Glycosphingolipid changes induced by advanced glycation end-products.
Natalizio A; Ruggiero D; Lecomte M; Lagarde M; Wiernsperger N
Biochem Biophys Res Commun; 2001 Feb; 281(1):78-83. PubMed ID: 11178963
[TBL] [Abstract][Full Text] [Related]
5. Changes in ganglioside and sialic acid contents of goat milk during lactation.
Puente R; Garcia-Pardo LA; Rueda R; Gil A; Hueso P
J Dairy Sci; 1994 Jan; 77(1):39-44. PubMed ID: 8120206
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of antimitotic thioglycosides: in vitro and in vivo evaluation of their anticancer activity.
García-Álvarez I; Groult H; Casas J; Barreda-Manso MA; Yanguas-Casás N; Nieto-Sampedro M; Romero-Ramírez L; Fernández-Mayoralas A
J Med Chem; 2011 Oct; 54(19):6949-55. PubMed ID: 21866909
[TBL] [Abstract][Full Text] [Related]
7. [Glycosphingolipids of human aorta].
Prokazova NV; Mikhaĭlenko IA; Gladkaia EM; Sadovskaia VL; Kogtev LS
Bioorg Khim; 1986 Oct; 12(10):1405-13. PubMed ID: 3814185
[TBL] [Abstract][Full Text] [Related]
8. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
9. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
[TBL] [Abstract][Full Text] [Related]
10. Shedding of gangliosides by human medulloblastoma cells.
Chang F; Li R; Ladisch S
Exp Cell Res; 1997 Aug; 234(2):341-6. PubMed ID: 9260903
[TBL] [Abstract][Full Text] [Related]
11. [The composition of glycosphingolipids and the effect of neuraminidase on cultured glioma cell lines].
Li ZX; Iwamori M; Nagai Y; Shitara N; Takakura K
No To Shinkei; 1989 Apr; 41(4):347-52. PubMed ID: 2765299
[TBL] [Abstract][Full Text] [Related]
12. The metabolic processing of glycosphingolipids in HT-29 cells is differentiation-dependent.
Houri JJ; Falbo A; Vignali G; Codogno P; Ghidoni R
Biochem Biophys Res Commun; 1994 Jul; 202(2):992-1000. PubMed ID: 8048973
[TBL] [Abstract][Full Text] [Related]
13. Metabolic pathways and intracellular trafficking of gangliosides.
Daniotti JL; Iglesias-Bartolomé R
IUBMB Life; 2011 Jul; 63(7):513-20. PubMed ID: 21698755
[TBL] [Abstract][Full Text] [Related]
14. Significance of glycosphingolipid fatty acid chain length on membrane microdomain-mediated signal transduction.
Iwabuchi K; Nakayama H; Iwahara C; Takamori K
FEBS Lett; 2010 May; 584(9):1642-52. PubMed ID: 19852959
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of glycoside inhibitors of glioma and melanoma growth.
García-Alvarez I; Corrales G; Doncel-Pérez E; Muñoz A; Nieto-Sampedro M; Fernández-Mayoralas A
J Med Chem; 2007 Jan; 50(2):364-73. PubMed ID: 17228879
[TBL] [Abstract][Full Text] [Related]
16. Polymeric drugs based on random copolymers with antimitotic activity.
López-Donaire ML; Parra-Cáceres J; Fernández-Gutiérrez M; Vázquez-Lasa B; Román JS
Biomacromolecules; 2010 Sep; 11(9):2478-86. PubMed ID: 20695637
[TBL] [Abstract][Full Text] [Related]
17. Changes in liver gangliosides in streptozotocin-induced diabetic rats.
Sánchez SS; Abregú AV; Aybar MJ; Sánchez Riera AN
Cell Biol Int; 2000; 24(12):897-904. PubMed ID: 11114239
[TBL] [Abstract][Full Text] [Related]
18. Subcellular biosynthesis and transport of gangliosides formed from exogenous lactosylceramide in rat liver.
Trinchera M; Ghidoni R
Biochem J; 1990 Mar; 266(2):363-9. PubMed ID: 2317192
[TBL] [Abstract][Full Text] [Related]
19. N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
Baek RC; Kasperzyk JL; Platt FM; Seyfried TN
Neurochem Int; 2008 May; 52(6):1125-33. PubMed ID: 18207611
[TBL] [Abstract][Full Text] [Related]
20. Glycosphingolipid expression in solid tumours and transformed cell lines.
Berra B; Colombo I; Monteggia E; Montorfano G; Moretti S; Rapelli S; Sottocornola E
Indian J Biochem Biophys; 1997; 34(1-2):170-7. PubMed ID: 9343946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
